Le Lézard
Classified in: Health
Subjects: DIS, DEI

HARMONIC BIONICS PARTNERS WITH HEALTHLINK HOLDINGS LTD. TO DISTRIBUTE THE HARMONY SHRtm ROBOTIC REHABILITATION SYSTEM IN HONG KONG AND MACAU


AUSTIN, Texas, Aug. 2, 2022 /PRNewswire/ -- Harmonic Bionics, the robotics company for augmenting human movement, announced today that Healthlink Holdings Ltd. will be the exclusive distributor of Harmony SHRtm in the Hong Kong and Macau territories. Healthlink will begin purchasing systems following FDA registration of Harmony SHR and a full commercial launch next year.

Harmony SHR's anatomically matched shoulder design allows a larger and more natural range of motion for patients recovering from neurological or musculoskeletal impairments compared to other upper extremity exoskeletons on the market today.  Harmony was also built to help facilitate evidence-based principles in a rehab session, such as mirror therapy that has shown to improve outcomes in chronic stroke patients.

"The incidence of stroke in Hong Kong has increased over 50% in the last ten years so we know that there is a need for technology and innovation to help recovering patients," said Healthlink Holdings Sales & Marketing Director Samuel Chan. "While we have been in the rehabilitation robotics industry for many years, we have never seen an upper extremity device like Harmony SHR that can address both neurological and orthopedic markets with its shoulder functionality and assessment capabilities, so we are excited to help make this available to patients and providers in Hong Kong and Macau."

"While we are primarily focused on the US market at this stage, we are always looking for partnerships in territories that will help grow the adoption of our technology worldwide," said Harmonic Bionics CEO Christopher Prentice. "With Healthlink's existing relationships with public and private hospitals and sports clinics in Hong Kong and Macau, they will be a great ally for Harmonic Bionics."

For more information about Harmony SHR, visit harmonicbionics.com or email [email protected].

About Harmonic Bionics, Inc.

Harmonic Bionics, the robotics company for augmenting human movement, aims to empower patients and their care providers by designing intelligent technology that facilitates data-driven treatment for neurological and musculoskeletal movement impairments. Our flagship product, Harmony SHR, is a bilateral upper extremity exoskeleton designed to provide unique value in three areas of practice:  neuroscience and movement science research, movement disorder assessment, and rehabilitation. 

About Healthlink Holdings Limited

Healthlink Holdings Limited was established in 2008, focusing on the marketing and selling of innovative and high-tech medical, rehabilitation and sport science equipment in Hong Kong and Macau.  The company's leadership team has over 30 years of experience in marketing pharmaceutical, medical, and rehabilitation products and represents many world-renowned manufacturers.

SOURCE Harmonic Bionics


These press releases may also interest you

at 07:35
Scipher Medicine, an AI-enabled precision immunology company, today announced the appointment of Reginald Seeto, MBBS*, as Chief Executive Officer and President. Scipher developed SpectraTM, a proprietary AI platform that has been used to build both...

at 07:35
Merrimack Pharmaceuticals, Inc. ("Merrimack" or the "Company") today announced that the Board of Directors intends to declare a liquidating cash dividend in the amount of $15.10 per share, if stockholder approval of the Plan of Dissolution is...

at 07:35
Nvelop Therapeutics, a biotechnology company engineering programmable, non-viral vehicles for the in vivo delivery of therapeutic cargo, today announced the presentation of new preclinical data from its DLVR-M platform at the 27th annual meeting of...

at 07:30
Knight Therapeutics Inc. ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has entered into an exclusive supply and distribution agreement with Ironshore Pharmaceuticals & Development, Inc., a wholly owned...

at 07:30
Cronos Group Inc.   ("Cronos" or the "Company"), today announces its 2024...

at 07:30
Calico Life Sciences LLC (Calico) and the Broad Institute of MIT and Harvard, announced today that the two organizations have further extended their partnership with an added focus on age-related neurodegeneration. Initially announced in March 2015,...



News published on and distributed by: